These evidences suggest that RETNLB is expected to be a potential biomarker in some tumors, and led us to suspect that RETNLB may also play a role in oral squamous cell carcinoma, which has not yet been reported. The gene discussed is RETNLB; the disease is oral cavity squamous cell carcinoma.